Candidates must normally possess:
- at least a second class honours degree in Life Science or Pharmacy/Pharmacology from a university in the United Kingdom; or
- a qualification deemed by the Joint Management Committee to be equivalent to the above; and/or
- professional or industrial experience deemed appropriate by the Joint Management.
There are a limited number of places on this programme so early application is recommended. Please note that applications are considered incomplete and will not be sent to the reviewers until the following documents are uploaded.
- Personal statement highlighting your career goals and how this programme will help you achieve them. Your personal statement must include the campus where you would prefer to be based, Glasgow or Aberdeen.
- Scottish Funding Council postgraduate funded places form
- 2 satisfactory supporting reference letters
- Academic transcripts to date
Months of entry
This specially funded programme is awarded by the Universities of Glasgow, Aberdeen and Strathclyde, and in collaboration with the Universities of Dundee and Edinburgh. Students can be based in either Glasgow or Aberdeen, and should indicate the preferred campus in their application.
Stratified Medicine holds huge potential in the timely development of new treatments for human disease. It is among the most important concepts to emerge in 21st century clinical science and will be a crucial component of the global drive to increase the efficacy, safety and cost effectiveness of new treatments. This new taught postgraduate Masters programme draws on the current and future needs of the Life Sciences sector, to create a highly skilled workforce and is being developed in conjunction with the industrial partners of the Stratified Medicine Scotland Innovation Centre (SMS-IC). It harnesses Scotland’s strengths in Stratified Medicine, Clinical Trials, Bioinformatics and Pharmacogenomics to provide focused training which integrates basic and clinical sciences, and equips students with grounding in the essential skills required to design, execute and evaluate modern clinical interventions.
- Students will be given the unique opportunity to undertake an industry placement as their main project. This fantastic opportunity will be offered by partner commercial organisations/companies and universities.
- The programme will cover aspects of commercial innovation and entrepreneurial skills, together with the principles which underpin the emerging science at the interface between genetics and pharmacology.
- Students on the programme will undergo theoretical and practical training in state-of-the-art research processes, enabling an appreciation of how to applynovel stratified approaches, together with clinical pharmacological, regulatory and ethical principles to the optimisation of future clinical research and therapeutic practice.
- Students will also gain an understanding of statistical methods used to evaluate the efficacy and cost-effectiveness of new treatments, and direct experience of how all of these techniques are applied by academic and industrial researchers in the development of new medicines.
- Following successful completion of the programme a joint master’s degree will be awarded.
- The five stakeholder universities, Glasgow, Aberdeen, Strathclyde, Dundee and Edinburgh are internationally recognised as leaders in biomedical research, hosting highly collaborative and productive groups with the requisite expertise in pharmacology, clinical trial methodology, pharmacogenomics, and life sciences. This vibrant environment, coupled with Scotland’s tradition of excellence in clinical research and significant recent investment in the new science of Stratified Medicine make it the ideal place to acquire the transferrable skills required for a successful and fulfilling career in 21st century biomedicine.
Information for international students
Fees and funding
Qualification and course duration
Course contact details
- MVLS SMPI